ArticlePDF AvailableLiterature Review

The psychological impact of alopecia

Authors:

Abstract

Alopecia is a chronic dermatological disorder in which people lose some or all of the hair on their head and sometimes on their body as well. It is a chronic inflammatory disease that affects the hair follicles. It is neither life threatening nor painful, though there can be irritation of the skin, as well as physical problems resulting from the loss of eyelashes and eyebrows. The aetiology and subsequent development of alopecia is not fully understood, but it is an autoimmune disorder that arises from a combination of genetic and environmental influences.1 We have included alopecia secondary to chemotherapy in the current review as, although there are fundamental aetiological differences, they may share similarities—for example, anxiety arising from the alopecia and the psychological impact relating to identity. Alopecia has few physically harmful effects, but may lead to psychological consequences, including high levels of anxiety and depression. Medical treatment for the disorder has limited effectiveness, and the failure to find a cure can leave patients very distressed. This article reviews the research into the psychological impact of alopecia. We conducted the searches for this clinical review in September 2005 through Ovid, focusing particularly on Medline, PsycINFO, ScienceDirect, the Cochrane Library, and the Web of Science. Searches went as far back as 1980. The main terms used were: alopecia, stress, psychology, treatment, anxiety, depression, and trauma. We also examined the reference lists of articles found. We included all studies that focused on the psychological consequences of alopecia, irrespective of method used. Studies were excluded if they focused on androgenetic alopecia. We included studies relating to hair loss from chemotherapy, as some of the evidence shows that such hair loss can be psychologically damaging beyond the impact of the chemotherapy. We included a total of 34 studies in the analysis (table). …
June 2007
362
The Psychologist Vol 20 No 6
The psychological
impact of alopecia
H
AIR loss is usually thought of as
something men start worrying
about as they get older. But there
are various forms of hair loss, often
extensive and sudden, which can impact on
anyone – male or female – at any time.
There are three main forms,
distinguished largely by the extent of the
loss: alopecia areata, referring to the
partial loss of hair from the head, usually
patchy rather than general thinning;
alopecia totalis, which is the loss of all
head hair; and alopecia universalis, the
loss of all head and body hair. We will
refer to these three as ‘alopecia’ in this
article, and while some of the issues may
also relate to male pattern baldness
(alopecia androgenetica), we are not
specifically concerned with this.
Psychologists have largely neglected
alopecia. There has been very little
research carried out specifically by
psychologists; dermatologists and other
medical practitioners have conducted most
of it. Our aim is to describe the disorder,
outline the psychological research that has
been carried out, and provide some
questions that researchers and practitioners
might wish to address.
The extent of the problem
Alopecia is a chronic inflammatory disease
that affects the hair follicles, and it can
affect men, women or children at any age.
The aetiology and subsequent development
of alopecia is not fully understood, but it is
an autoimmune disorder that arises as a
combination of genetic and environmental
influences (Madani & Shapiro, 2000). The
hair follicles in the anagen stage of
development (growth phase) become the
target for immune cell attack. Why they are
attacked is – again – not fully understood,
but it appears to be a complex relationship
between individual characteristics (e.g.
immune system problems, personality,
coping styles) and the environment (e.g. a
stressful situation).
There is an estimated lifetime risk of
alopecia of 1.7 per cent (Kalish & Gilhar,
2003), though the actual figure is unknown
because many people with alopecia do not
present to the medical community. If the
figure is accurate, that would indicate that
around one million people suffer from
alopecia in the UK at some point in their
life. There is controversy over the rate at
which alopecia is expressed as alopecia
totalis or alopecia universalis. The extent of
the more severe forms of alopecia is
disputed, as there have been no relevant
epidemiological studies; figures from 7 per
cent to 30 per cent have been suggested.
Alopecia is neither life-threatening nor
painful, though there can be irritation of the
skin, weakness of the fingernails, and
physical problems resulting from the loss
of eyelashes and eyebrows. Eyelashes and
brows are surprisingly effective against the
rain, and eyelashes help turn the eyelid
outwards. Without eyelashes the lids turn in
and irritate the cornea, similar to constantly
having grit in the eye.
There is a relationship between the
extent of hair loss and the chances of it
growing back again. The more hair is lost,
the lower the likelihood of regrowth. If the
hair does grow back, there may be repeated
episodes of hair loss. The hair which grows
back may be different in terms of colour
and texture.
Treating alopecia
There is a range of medical treatments for
alopecia, but unfortunately there is no good
evidence that they have more than limited
long-term effectiveness. Treatment is
generally ineffective for the more serious
types of alopecia (totalis and universalis),
while the evidence relating to alopecia areata
is less clear. In many cases the problem
resolves itself, and any treatment can take
three to six months to be effective. Topical
application of corticosteroids is a common
treatment for alopecia, though if they are
taken for prolonged periods of time there
are potentially serious side effects.
Diphenylcyclopropenone (DPCP) is also
used, with varying results – while there is
initially some success, there is a high relapse
rate (Aghaei, 2005). Minoxidil is also used;
again it has limited effectiveness for alopecia
areata, though it is the only treatment
recommended for use by women with hair
loss (Messenger & Rundegren, 2004).
Dobbins et al. (2003), currently
conducting a Cochrane systematic review
of treatments, have found no good clinical
evidence for the effectiveness of any of the
treatments for alopecia. While some studies
show that there is regrowth, spontaneous
regrowth does occur without treatment,
particularly with patchy hair loss (alopecia
areata), and the studies that have been
carried out do not account for this with
NIGEL HUNT and SUE MCHALE
on the limited research and the need
for more.
CASE STUDY
I used to be very proud of my hair. It was almost black, and went
down to my waist. Everyone told me how nice it looked. I didn’t
think about it at the time, but it somehow made me the person I
was.After my accident my hair fell out very quickly – it was gone
within a few weeks.When I looked in the mirror the person I saw
looking back was not me. It was someone else. It is very difficult
to describe when I mean by that, but simply because I do not
have any hair I am now a different person; and I behave differently
with people. Inside I still remember who I was, but in everything I
do, I think I am someone else.
Helen, quoted in Hunt & McHale (2004)
suitable controls. Furthermore, the
treatments can be length and painful,
and cease to be effective when stopped.
Clearly, while alopecia can be
psychosocially damaging, there may also
be psychological consequences resulting
from the treatment itself. If it is prolonged
and of limited effectiveness, this may
impact on the person’s psychological well-
being. Also, knowing that medical treatments
have limited effectiveness will impact on
the way a psychologist deals with alopecia
because it is often a matter of helping the
person learn to live with alopecia rather than
seek a means of enabling the hair to regrow.
Psychology and alopecia
Alopecia can have serious psychosocial
consequences, causing intense emotional
suffering, and personal, social and work-
related problems. Surveys have shown that
around 40 per cent of women with alopecia
have had marital problems, and around 63
per cent claimed to have career-related
problems (Hunt & McHale, 2004).
Alopecia also leads to depression,
anxiety and social phobia in a number of
sufferers. This relationship between
alopecia and psychosocial consequences
can be complicated, in that alopecia can
result from a stressful experience, and then
itself lead to further distress. Limited
research has been carried out in the area.
There is evidence that stressful life
events have an important role in triggering
some episodes of alopecia (Garcia-
Hernandez et al., 1999). Women who
experience high stress are 11 times more
likely to experience hair loss than those
who do not report high stress (York et al.,
1998). Compared with the general
population, increased prevalence rates of
psychiatric disorders are associated with
alopecia (Koo et al., 1994) suggesting that
people with alopecia may be at higher risk
for development of a major depressive
episode, anxiety disorder, social phobia or
paranoid disorder. Egele and Tauschke
(1987) identified a group of alopecia
patients with an ongoing feeling of loss,
suggesting that for some individuals the
process of coping with alopecia may be
equated with the grieving process
following bereavement.
Furthermore, alopecia is a disfiguring
disorder and therefore there are also issues
relating to self and identity. The loss of
hair, particularly the eyelashes and brows
which help to define a person’s face, means
that a person looks very different. Hair loss
may be seen as a failure to conform to the
norms of physical appearance within
society, a situation which has the potential
to set people apart in their own estimation
and in the estimation of others.
Overall, there has been little systematic
research into alopecia’s psychological
consequences
(Hunt & McHale, 2005a).
Our research
We have used a variety of methods,
questionnaires and interviews, to examine
the relationship between alopecia and
psychological factors (Hunt & McHale,
2005b). We have also reviewed the
literature relating to psychological
consequences of alopecia. What follows is
a brief synopsis of our findings so far.
We collected questionnaires and e-mail
interviews with individuals with alopecia,
ranging in age from 12 to 93 years. There
is no claim here that the sample is
representative of people with alopecia. As
is often the case, those with no problems
and those with the most extreme problems
are probably less likely to volunteer to take
part. In fact, the majority of our sample
were women. While we suspect that
alopecia is not more common in women,
there are a number of reasons why they
may be more likely to volunteer. Women
are more likely to want to talk about their
alopecia because the disorder can be more
difficult for them. Put simply, in our culture
a bald man is socially acceptable, a bald
woman is not.
Theme Subcategory Examples
Personal Physical effects
Causes
Psychological distress
Eyes dry and sore
Times of stress
I fell over and was knocked unconscious
Distressing condition
I seriously considered suicide
Difficult to come to terms with
Don’t have to visit the hairdresser
Identity Coping I deliberately set about changing how I viewed my life
Profound effect on my life
Social Social
Work
Relationships
Sex differences
Children and adolescents
Social support
I am more reclusive
I do think people make comments and I feel humiliated
Off work with stress… couldn’t perform my job to the best
of my ability
I felt sensitive to student comment
[Family] cannot comprehend the significance of the loss
Never seen a bald woman out shopping
Losing one’s hair affects men as much as women
Not much fun being a bald teenager
Embarrassing at that age
I was teased a lot
Great support from husband
Extremely difficult to adjust to her baldness
A bald child is handy for getting rid of unwanted visitors
Medical Treatment
Doctors’ attitudes
Travelled the country to find a cure
I only wish there was a miracle cure
Scalp always sore
Large water blisters, headaches
Consultants not interested in your psychological well-being
No help, support or advice… hospital very dismissive and
unhelpful
It is dismissed by doctors as being trivial… ‘it is only your
pride that is hurt’ said one doctor
TABLE 1: Summary of themes and subcategories
June 2007
363
www.thepsychologist.org.uk
Alopecia
June 2007
364
The Psychologist Vol 20 No 6
Alopecia
The analysis of the qualitative data
proved most interesting, generating a
number of themes (Hunt & McHale,
2005b). The examples in Table 1 are
illustrative of the kinds of quotations we
obtained. Many of the participants
desperately wanted to find out why they
had alopecia, and searched everywhere for
a cure. Others had issues regarding their
relationships, with some spouses being
very supportive, and in some cases the
alopecia was the catalyst to end a
relationship.
Some people could not go outside or go
to work for fear of being mocked. Women
in particular described having problems,
perhaps because of the importance of hair
to a woman’s notion of self and identity.
Children and adolescents had problems, not
just because they might be bullied at
school, but because they are the ones going
through the stages of establishing identity.
If one’s physical appearance changes
abruptly at this point, then this can have
catastrophic consequences.
These issues surrounding relationships
demonstrate the importance of identity and
selfhood, and how one’s identity is not just
personal, but bound up in the physical and
social worlds. These findings are similar to
those obtained for other types of
fundamental appearance change or physical
disfigurement, which often have profound
psychosocial effects (e.g. Rumsey &
Harcourt, 2005). Visible skin disorders
having social anxiety and social avoidance
implications simply because they are
visible, irrespective of any physical
problems associated with the disorder.
Further research needed
We are currently undertaking further
research relating to the psychosocial
consequences of alopecia. There is a lot to
be done. One important psychological issue
involves establishing the role of physical
appearance in defining identity. Previous
research has examined identity construction
generally, but people with alopecia are a
population for whom physical appearance
is heightened. Their experiences,
particularly when eyebrows and lashes are
affected, may be compared with others
who experience facial disfigurement. It is
likely that there is a differential impact on
men, women and children.
The role of psychological trauma as
both a precursor and a consequence of
alopecia should be examined. There is a
need to examine the role of coping and
social support, the latter being seriously
affected by the change in appearance of the
individual with alopecia. The role of
personality and individual differences
should be examined, as it is possible that
particular types of people are more prone
to alopecia.
It is also important to establish links
between psychological and physiological
mechanisms. The evidence points to the
importance of the interaction between
individual characteristics and the
environment. For instance, some theories
of stress propose that self-efficacy is a
powerful factor in mediating stress.
Bandura et al. (1982) suggested that self-
efficacy may moderate immuno-supression,
and this may be relevant to the course of
alopecia.
A strong theoretical understanding of
the psychological impact of alopecia is
required. This will involve carrying out
research drawing together our understanding
of the immune system, the stress response,
and psychological responses. A
psychoneuroimmunological understanding
of alopecia should be developed, as there is
a strong interaction between physiological
and psychological responses.
Finally, it is critical that psychologists
are able to provide appropriate treatment
for people who are severely psychologically
affected by their hair loss. Appropriate
treatment strategies and regimes should be
established and disseminated among
therapists and others responsible for the
care of people with alopecia.
Hair loss has profound social
implications. Within the general population
people ascribe great importance to physical
appearance. Social relationships and social
support severely impact upon coping with
changes in appearance, which may lead to
identity change. From the limited evidence
that is available we can see that alopecia
can have profound effects on an
individual’s life. There is a strong need for
further research leading towards a fuller
psychological understanding of the
implications of alopecia.
Dr Nigel Hunt is at the Institute of
Work, Health & Organisations, the
University of Nottingham. E-mail:
nigel.hunt@nottingham.ac.uk.
Dr Sue McHale is at Sheffield Hallam
University. E-mail: s.l.mchale@shu.ac.uk.
Aghaei, S. (2005).Topical immunotherapy
of severe alopecia areata with
diphenylcyclopropenone (DPCP):
Experience in an Iranian
population. BMC Dermatology, 5,6.
Bandura,A., Reese, L. & Adams, N.E.
(1982). Micro-analysis of action
and fear arousal as a function of
differential levels of perceived self-
efficacy. Journal of Personality and
Social Psychology, 43, 5–21.
Dobbins, H.M., Delamere, F.M., Sladden,
M.J. & Sinclair, R. (2003).
Interventions for alopecia areata.
(Protocol) Cochrane Database of
Systematic Reviews, Issue 4.
Egele, U.T. & Tauschke, E. (1987). Die
Alopezie: Ein psychosomatisches
Krankheitsbild. Psychoter
Psychosomatic Medical Psychology,
37, 31–35.
Garcia-Hernandez, M.J., Ruiz-Doblado,
S., Rodriguez-Pichardo,A. &
Camacho, F. (1999).Alopecia
areata: Stress and psychiatric
disorders:A review. The Journal of
Dermatology, 26, 625–632.
Hunt, N. & McHale, S. (2004). Coping
with alopecia. London: Sheldon
Press.
Hunt, N. & McHale, S. (2005a). Clinical
review:The psychological impact
of alopecia. British Medical Journal,
331, 951–953.
Hunt, N. & McHale, S. (2005b).
Reported experiences of persons
with alopecia areata. Journal of Loss
and Trauma, 10, 33–50.
Kalish, R.S. & Gilhar, A. (2003).Alopecia
areata:Autoimmunity – evidence is
compelling. Journal of Investigative
Dermatology, 8, 164–167.
Koo, J.Y., Shellow,W.V., Hallman, C.P. &
Edwards, J.E. (1994).Alopecia
areata and increased prevalence of
psychiatric disorders. International
Journal of Dermatology, 33, 849–850.
Madani, S. & Shapiro, J. (2000).Alopecia
areata update. Journal of the
American Academy of Dermatology,
42, 549–566.
Messenger,A.G. & Rundegren, J. (2004).
Minoxidil: Mechanisms of action
on hair growth. British Journal of
Dermatology, 150, 186–194.
Rumsey, N. & Harcourt, D. (2005). The
psychology of appearance.
Maidenhead: Open University Press.
York, J., Nicholson,T. & Minors, P.
(1998). Stressful life events and
loss of hair among adult women:A
case-control study. Psychological
Reports, 82, 1044–1046.
References
WEBLINKS
Alopecia UK: www.alopeciaonline.org.uk
Information and links: www.keratin.com/index.shtml
Regrowth of hair after alopecia totalis
DR P. M ARAZZI/SCIENCE PHOTO LIBRARY
... Supportive interventions such as guided self-image therapy, group counseling, or structured psychosocial programs have been shown to reduce emotional distress in patients dealing with chronic or unpredictable hair loss. These interventions have been shown to reduce emotional distress and may improve treatment outcomes for patients with visible hair loss [38]. ...
... These variations influence how individuals interpret their condition and how likely they are to seek treatment or report emotional distress. Recognizing these cultural differences allows clinicians to provide more personalized, empathetic care and helps ensure that patient expectations and concerns are addressed in a way that feels relevant and respectful [38]. ...
... These culturally embedded narratives influence not only the degree of psychological distress but also the likelihood of seeking treatment. Clinicians who remain attuned to such cultural dimensions are better equipped to deliver care that is both empathetic and contextually appropriate, fostering more meaningful communication and alignment with patient expectations [38,39]. ...
... Alopecia, or hair loss, can affect any sex at any age and poses a significant psychological burden. Roughly 40% of women reported that their hair loss contributed to marital problems, while 63% reported career problems [1]. Alopecia is categorized into non-cicatricial (nonscarring) and cicatricial (scarring). ...
... Current topical treatments for androgenetic alopecia include minoxidil, which increases blood flow to the 1 1 1 1 1 follicles by inhibiting potassium-ATPase channels, and finasteride, an oral 5-alpha-reductase inhibitor that obstructs DHT activity, leading to hair regrowth. Minoxidil and dutasteride (which has a similar mechanism to finasteride) can also be given orally to patients. ...
Article
Full-text available
The objective of this scoping review was to understand the extent and type of evidence found in the current literature on the delivery mechanisms of exosome therapeutics and how these methods can work synergistically with existing treatments for alopecia. Alopecia is primarily characterized as non-scarring or scarring (cicatricial). In cicatricial alopecia, the hair follicles are irreversibly destroyed, causing permanent hair loss. In non-cicatricial alopecia, the hair follicles are undamaged, allowing for possible hair regeneration. Non-scarring alopecia includes androgenetic alopecia, telogen effluvium, and alopecia areata. Current treatments for non-scarring alopecia include oral minoxidil and spironolactone. Exosome therapeutics are a possible alternative treatment for non-scarring alopecia because of their regenerative properties in hair follicle stimulation, customizable size selection, and the potential to activate and down-regulate specific pathways that enhance hair growth. This review evaluates types and sources of exosome delivery as regenerative treatments for alopecia. A search of literature published in English from 2018 to 2023 was performed using the electronic databases EMBASE, Ovid MEDLINE, and Web of Science. Data from selected studies included specific details about the participants, concept, context, study methods, and key findings relevant to the review questions. Upon completion of the database search that yielded 1,087 citations, after removing 284 duplicates, 803 articles remained for assessment of eligibility. Finally, 16 studies were retained for inclusion. These studies explored one or more exosome delivery techniques, such as intradermal needle injection, microneedle patches, topical application, and topical application with a secondary assistive device. The therapeutic focus of these studies ranged from hair follicle regeneration and wound healing to spinal cord injury repair and collagen regeneration for cosmetic purposes. Most of the studies (14 out of 16) used exosomes derived from mesenchymal stem cells (MSCs), while others isolated exosomes from human adipose stem cells, macrophage cell lines, and dermal fibroblast cells. Of the 16 studies, all but two administered exosomes via microneedle patches. The findings suggest that intradermal microneedle patches are a promising method for delivering exosomes into tissues, particularly for the treatment of non-cicatricial alopecia. Exosome therapy shows strong potential for promoting hair follicle regeneration, supported by its proven efficacy in wound healing, spinal cord injury repair, and cosmetic applications. Among the various delivery methods explored, microneedle patches loaded with exosomes from MSCs emerged as the most effective for targeted delivery into tissues. These findings support exosome-based therapies for non-cicatricial alopecia.
Article
Androgenetic alopecia (AGA) is associated with dihydrotestosterone (DHT)-induced apoptosis in human dermal papilla cells (HDPCs) via androgen receptor (AR) upregulation. This study aimed to evaluate the potential of Cucumis melo var. makuwa leaf extract (CLE) to attenuate these DHT-mediated effects in HDPCs. HDPCs were treated with CLE, and DHT-induced apoptosis and AR expression were assessed. High-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (HPLC–ESI–MS) identified Meloside A as the principal bioactive constituent within CLE. CLE significantly attenuated DHT-induced apoptosis in HDPCs, demonstrating a 57.74% reduction at 1000 ppm. Mechanistically, Meloside A inhibited DHT-stimulated AR nuclear translocation and reduced AR protein expression. Furthermore, Meloside A decreased the expression of downstream target genes at 100 ppm, showing a 16.27% reduction in IL-6, a 26.55% reduction in TGF-β1, and a 35.38% reduction in DKK-1. Additionally, Meloside A significantly inhibited ROS generation within DHT-stimulated HDPCs by 45.45% at 100 ppm. These findings suggest that Meloside A, isolated from CLE, exerts anti-AGA effects by modulating AR nuclear translocation and gene expression. This highlights its potential as a therapeutic agent for AGA and provides a basis for developing novel therapeutic strategies for hair loss.
Article
Dermatologists face diagnostic and therapeutic challenges pertinent to the treatment of older adults facing hair growth disorders. The rapidly growing geriatric population have age-related physiological and pathological changes that contribute to alterations in hair growth patterns, texture, and pigmentation through their lifetime. This review examines the general pathophysiology and clinical presentations for hair growth disorders to help clinicians gain a better understanding of the disorders. A combination of therapies and medications improves the conditions. Additionally, psychosocial implications of hair disorders in older adults are discussed, indicating the importance of a patient-centered, multidisciplinary approach to hair loss management in modern healthcare. With a better understanding of common hair disorders, providers of healthcare will be better prepared to address the specific concerns of our aging population.
Article
Full-text available
Background Scant evidence exists for the relative efficacy of therapies for alopecia areata (AA)—including those approved by the Food and Drug Administration, namely, baricitinib, deuruxolitinib, and ritlecitinib. Aims We determined the relative efficacy and safety of monotherapy with janus kinase inhibitors (JAKIs), apremilast, and dupilumab. Methods Following a systematic review, we conducted Bayesian network meta‐analysis (NMAs) that produced Surface Under the Cumulative RAnking (SUCRA) values and point estimates for pairwise relative effects; we also performed sensitivity analyses. Results In total, regimens with eight various JAKIs were compared, namely, ruxolitinib, ATI‐501, baricitinib, brepocitinib, deuruxolitinib, ivarmacitinib, ritlecitinib, and tofacitinib. Our analyses ranked “deuruxolitinib 12 mg twice daily for 24 weeks,” the most efficacious insofar as “proportion of participants achieving SALT ≤ 20 at 24 weeks” (SALT20) (SUCRA = 92.6%), and “proportion of participants achieving SALT ≤ 10 at 24 weeks” (SALT10) (SUCRA = 97.7%). As per SALT20, the highest‐ranked regimen was more efficacious than “baricitinib 2 mg once daily for 24 weeks” (odds ratio [OR] = 5.37, 95% credible interval [CI] = 1.59, 13.70, p < 0.05). Furthermore, the efficacy of the FDA‐approved JAKIs exhibited a dose‐dependent relationship; for instance, baricitinib 4 mg once daily for 24 weeks was more efficacious than “baricitinib 2 mg once daily for 24 weeks” in terms of SALT20 (OR = 2.25, 95% CI = 1.56, 3.21, p < 0.05). Results from our sensitivity analyses support that our base analyses were robust. Conclusions We produced high‐quality evidence on the comparative effectiveness of monotherapies for AA with various regimens of 8 JAKIs, including the FDA‐approved ones. Our findings can improve clinicians' decision‐making and update guidelines for medical practice.
Article
Full-text available
Hair loss profoundly impacts millions worldwide, affecting both physical appearance and psychological well-being. Tissue engineering holds promise in addressing hair loss through the development of bioengineered follicles that integrate seamlessly with native tissue. Nanoparticle-based drug delivery systems, like hybrid nanoparticles with extracellular vesicles, nanoparticles, and finasteride, enhance therapeutic outcomes. Temperature-sensitive biopolymers and stem cell membrane-loaded minoxidil nanoparticles improve solubility, sustained release, and localized delivery for hair growth. Advances in biomaterials, such as bioinks and plant-derived nanoparticles, expand treatment possibilities. This review explores current understanding of hair follicle regeneration, emphasizing the pivotal roles of cells, biomaterials and nanoparticles.
Article
Full-text available
Androgenetic alopecia (AGA) is characterized with chronic and progressive hair loss, with psychological factors associated intensifying impact on patients. Current treatments, such as oral finasteride and topical minoxidil, have low...
Article
Full-text available
Background and Objectives: Alopecia areata (AA) is a common cell-mediated autoimmune disease of the hair follicle that results in hair loss patches, affecting males and females of all ages and ethnicities. Although its etiology is not fully understood, AA is hypothesized to have a multifactorial basis with a strong genetic association. This study aims to replicate the genetic association of several risk loci in the Jordanian population for the first time. Materials and Methods: Genomic DNA samples of 152 patients with AA and 150 control individuals were extracted from EDTA blood tubes collected from dermatology clinics, in addition to the clinical data of participants. Genetic sequencing of the 21 targeted risk loci was carried out using the Sequenom MassARRAY® system (iPLEX GOLD), and the results were statistically analyzed using the Statistical Package for the Social Sciences. Results: The results compared the distribution of alleles and genotypes and the association between control individuals and AA patients. However, our results do not support a significant association of all of the 21 SNPs in our AA cohort (p > 0.05). Conclusions: Our data emphasize that AA has a varied genetic component between ethnic groups and suggest that other additional environmental and psychological triggers may be involved.
Article
Full-text available
Background Hair loss is a serious health concern, with individuals having to bear the associated psychological impact of the condition. Alopecia has been linked to emotional and psychological anguish in relationships, career, and personal life. Objective This study aimed to elucidate the intricate association, prevalence, and impact of hair loss with anxiety disorders, distinguished from other psychological impacts of alopecia. Methods The current review and meta-analysis were performed in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) framework. A comprehensive search was performed using the Cochrane, PubMed, and Google Scholar electronic databases studies published in English and conducted between January 2014 and September 2024. Statistical analysis was performed using STATA version 16.0 (StataCorp LLC), and the Newcastle-Ottawa Scale and RoB 2 tools were used for critical quality appraisal. Results A total of 24 eligible articles were included in the current study, with a cumulative of 5553 patients presenting with 1 or more forms of hair loss. Anxiety disorder was significantly prevalent among patients with alopecia event rate (ER) 0.47 (95% CI: 0.39–0.54). Anxiety severity analysis also showed a significant relationship between anxiety and hair loss, with ERs of 0.35 (95% CI: 0.10–0.60), 0.15 (95% CI: 0.01–0.29), and 0.05 (95% CI: 0.03–0.29), respectively. Statistical significance was also demonstrated by a mean HADS-A score of 7.87 (95% CI: 6.85–8.88). However, considerable heterogeneity was observed in various statistical analyses. Conclusion In summary, our study showed that among people with hair loss-related diseases, alopecia was substantially linked to anxiety disorders, with the frequency of anxiety among those affected being noticeably higher.
Article
Full-text available
Object: Alopecia Areata (AA) is reported to account for 2% of dermatology clinical visits with incidence figures ranging up to 3.5 %. The role of stressful life events in the appearance of AA is uncertain. Besides reports associating anxiety and affective disorders with the onset of AA, there has also been studies which did not confirm such an association. There have been reports documenting the efficacy of antidepressants in AA. We wanted to see whether dermatological treatment and recovery in AA patients induces any change in psychometric variables. We wanted to test whether the well-being of patients after dermatological treatment has any association to psychic factors. Method: Eighteen patients were recruited in the study and they were assessed with Beck Depression and Hopelessness Scales, State-Trait Anxiety Inventory, Toronto Alexithymia Scale and Brief Symptom Inventory. Patients were given steroid therapy with 3 week intervals and they all responded favorably to treatment. Three months after initial assessment patients were reassessed with the same psychometric scales. Results: No statistically significant change was found. Conclussions: Despite the limitations of the study, this result may be interpreted as the independence of dermatological recovery from psychological factors. A placebo-controlled study is necessitated to further validate the results of this study.
Article
Full-text available
Alopecia is a chronic disease of hair loss. The study focuses on psychological issues relating to the experience of alopecia. Previous research has considered psychological problems as secondary to the medical disorder. The first part consisted of spontaneous written accounts (N = 162) of the experience of alopecia. The second part was an interactive email interview (N = 34). Findings focused on negative personal, social, and medical effects. Successful coping was discussed by very few respondents, but included behavioral changes and acceptance of appearance and identity changes. Suggestions are made for future research. Treatment for alopecia needs to be broadened to include psychological methods.
Article
Full-text available
Two experiments combining intergroup and intrasubject designs were conducted to test the hypothesis that self-percepts of efficacy operate as cognitive mediators of coping behavior and fear arousal. Differential levels of self-efficacy were induced in phobic subjects through either inactive mastery or modeling. Their coping behavior and accompanying fear arousal were then measured. In the next phase, self-efficacy was successively raised to designated levels within the same subjects, whereupon their behavior and fear arousal were again measured. Coping behavior corresponded closely to instated self-percepts of efficacy, with higher levels of perceived self-efficacy being accompanied by greater performance attainments. The efficacy-action relationship was replicated across different modes of efficacy induction, different types of behavioral dysfunctions, and in both intergroup and intrasubject comparisons. The hypothesis that fear arousal stems largely from perceived coping inefficacy also received support from the findings. As subjects' self-efficacy level was raised, they experienced progressively less anticipatory and performance distress while coping with threats. Results of a third experiment using cardiac acceleration and elevation in blood pressure as indicants of arousal further corroborate the generality of the relationship between perceived coping inefficacy and stress reactions.
Article
We have known for over 30 years that minoxidil stimulates hair growth, yet our understanding of its mechanism of action on the hair follicle is very limited. In animal studies, topical minoxidil shortens telogen, causing premature entry of resting hair follicles into anagen, and it probably has a similar action in humans. Minoxidil may also cause prolongation of anagen and increases hair follicle size. Orally administered minoxidil lowers blood pressure by relaxing vascular smooth muscle through the action of its sulphated metabolite, minoxidil sulphate, as an opener of sarcolemmal KATP channels. There is some evidence that the stimulatory effect of minoxidil on hair growth is also due to the opening of potassium channels by minoxidil sulphate, but this idea has been difficult to prove and to date there has been no clear demonstration that KATP channels are expressed in the hair follicle. A number of in vitro effects of minoxidil have been described in monocultures of various skin and hair follicle cell types including stimulation of cell proliferation, inhibition of collagen synthesis, and stimulation of vascular endothelial growth factor and prostaglandin synthesis. Some or all of these effects may be relevant to hair growth, but the application of results obtained in cell culture studies to the complex biology of the hair follicle is uncertain. In this article we review the current state of knowledge on the mode of action of minoxidil on hair growth and indicate lines of future research.
Article
The article reviews the literature on the psychogenesis of alopecia areata, supplemented by a brief presentation of recent immunological concepts concerning this disease pattern. General timidity and fearfulness, social aloofness and tendency to depression are considered common characteristics of the primary personality of alopecia patients. These features are interpreted as following an early disturbance in the mother-child relationship. Loss of hair is triggered by events involving loss or impending loss. Against the background of recently discovered psychoimmunological interrelationships an attempt is made to develop a hypothesis of a pathogenetic 'chain' that can integrate the various upsetting factors.
Article
The purpose of this study was to determine whether elderly patients receiving cancer chemotherapy experience more emotional distress, difficulty with side effects, and disruption in activities than younger patients. A sample of 217 patients receiving initial chemotherapy treatment for breast cancer or lymphoma was interviewed several times over the first 6 months of treatment. Patients ranged in age from 19 to 83. Included in the interviews were questions on presence, duration, and severity of side effects; response of disease to treatment; and 0-10 ratings of emotional distress, difficulty, and life disruption due to chemotherapy. Information on drugs given, doses, and schedules was obtained from medical charts. In general, elderly patients reported no more difficulty with treatment or emotional distress than did younger patients. This general pattern held across disease types, with some exceptions. These results, combined with previously published studies on the physiological effects of chemotherapy in the elderly, indicate that aggressive treatment should not be withheld from older patients simply because of their age.
Article
The chief goal of this exploratory study was to discover what a woman's own experience of her illness meant to her--how she thinks of herself as a woman and a person with a health problem. The study was exploratory in nature and designed to expand our conceptual thinking about health and illness and the delivery of health-care services. The study was qualitative, and the principal method was the semi-structured, indepth, face-to-face interview. All of the women in the study had been diagnosed with primary breast cancer and were in a variety of stages of treatment. What emerged from the study were explanatory stories that women constructed to chronicle their illness experience and interpret it. The theme under discussion here is hair loss as symbolic of larger cultural beliefs and values. Recommendations for interventions with women who experience hair loss as a traumatic event are offered in the context of a deeper cultural understanding of hair loss that is a consequence of cancer care.
Article
The relationship between psychiatric disorders and alopecia areata has not been well studied. Although previous reports have been unable to correlate psychiatric illness with hair loss, a recent study determined that 74% of patients with alopecia areata (AA) under evaluation had one or more lifetime psychiatric diagnoses. Two hundred and ninety-four community-based patients with alopecia areata responded to a detailed questionnaire distributed by Help Alopecia International Research, Inc. The prevalence of psychiatric disorders was determined using diagnostic criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM-IIIR). Major depression, generalized anxiety disorder, social phobia, and paranoid disorder were all present in patients with alopecia areata at rates significantly higher than in the general population. Alopecia areata patients are at a higher risk of developing psychiatric comorbidity during their clinical course.